ArticleTranslational lung cancer research2020

A case report of exceptional clinical response to chemoradiotherapy and tyrosine kinase inhibitors in a patient with EML4-ALK fusion variant 1 non-small cell lung cancer.

Xinyan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.